Kainos Medicine
₩1,087
0
-₩105-8.81% Thursday 05:14
Statistics
Day High
1,087
Day Low
1,087
52W High
1,087
52W Low
1,087
Volume
0
Avg. Volume
0
Mkt Cap
35.56B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-664.43%Profit Margin
Unprofitable1.17BRevenue
-7.78BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Kainos Medicine, Inc. engages in research and development of various medicines for cancers, brain, and infectious diseases in South Korea and internationally. The company's product pipeline includes KM-819, which is completed Phase I clinical study for the treatment of Parkinson's disease; and KM023, a novel non-nucleoside reverse transcriptase inhibitor that is in Phase III clinical study to treat HIV/AIDS. It is developing anticancer agents, including DNA methyltransferase inhibitor; gene target anti-cancer agent; and Ara-C, a cytotoxic anti-cancer agent to treat acute myeloid leukemia, as well as small molecule immuno-oncology drugs that modulate anti-cancer abilities of immune cells. In addition, the company is involved in the discovery of a Hepatitis B drug. It has a collaboration agreement with Emmaus Life Sciences, Inc. for the preclinical development of IRAK4 inhibitor as potential anti-cancer drug. The company was founded in 2007 and is headquartered in Seongnam-si, South Korea.
Show more...
CEO
Mr. Ki-Sub Lee
Country
South Korea
ISIN
KR7284620002
Listings
0 Comments
Share your thoughts
FAQ
What is Kainos Medicine stock price today?▼
The current price of 284620.KQ is ₩1,087 KRW — it has decreased by -8.81% in the past 24 hours. Watch Kainos Medicine stock price performance more closely on the chart.
What is Kainos Medicine stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Kainos Medicine stocks are traded under the ticker 284620.KQ.
What is Kainos Medicine market cap?▼
Today Kainos Medicine has the market capitalization of 35.56B
What is Kainos Medicine revenue for the last year?▼
Kainos Medicine revenue for the last year amounts to 1.17B KRW.
What is Kainos Medicine net income for the last year?▼
284620.KQ net income for the last year is -7.78B KRW.
In which sector is Kainos Medicine located?▼
Kainos Medicine operates in the Energy sector.
When did Kainos Medicine complete a stock split?▼
The last stock split for Kainos Medicine was on July 12, 2022 with a ratio of 1:5.
Where is Kainos Medicine headquartered?▼
Kainos Medicine is headquartered in Seongnam-si, South Korea.